nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Paclitaxel—ovarian cancer	0.116	0.164	CbGbCtD
Halofantrine—CYP2C8—Paclitaxel—ovarian cancer	0.112	0.157	CbGbCtD
Halofantrine—CYP2D6—Vinorelbine—ovarian cancer	0.102	0.143	CbGbCtD
Halofantrine—CYP3A4—Topotecan—ovarian cancer	0.0916	0.129	CbGbCtD
Halofantrine—CYP3A5—Docetaxel—ovarian cancer	0.0841	0.118	CbGbCtD
Halofantrine—CYP3A4—Vinorelbine—ovarian cancer	0.0645	0.0908	CbGbCtD
Halofantrine—CYP3A4—Paclitaxel—ovarian cancer	0.0454	0.0638	CbGbCtD
Halofantrine—CYP2D6—Doxorubicin—ovarian cancer	0.0384	0.0541	CbGbCtD
Halofantrine—CYP3A4—Docetaxel—ovarian cancer	0.0328	0.0461	CbGbCtD
Halofantrine—CYP3A4—Doxorubicin—ovarian cancer	0.0244	0.0344	CbGbCtD
Halofantrine—Arrhythmia—Vinorelbine—ovarian cancer	0.00155	0.00535	CcSEcCtD
Halofantrine—Anorexia—Chlorambucil—ovarian cancer	0.00154	0.00532	CcSEcCtD
Halofantrine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00154	0.00532	CcSEcCtD
Halofantrine—Cough—Topotecan—ovarian cancer	0.00154	0.00532	CcSEcCtD
Halofantrine—Cough—Melphalan—ovarian cancer	0.00151	0.0052	CcSEcCtD
Halofantrine—Rigors—Doxorubicin—ovarian cancer	0.0015	0.00519	CcSEcCtD
Halofantrine—Myalgia—Topotecan—ovarian cancer	0.0015	0.00519	CcSEcCtD
Halofantrine—Chest pain—Topotecan—ovarian cancer	0.0015	0.00519	CcSEcCtD
Halofantrine—Arthralgia—Topotecan—ovarian cancer	0.0015	0.00519	CcSEcCtD
Halofantrine—Convulsion—Melphalan—ovarian cancer	0.00149	0.00517	CcSEcCtD
Halofantrine—Discomfort—Topotecan—ovarian cancer	0.00148	0.00512	CcSEcCtD
Halofantrine—Chest pain—Melphalan—ovarian cancer	0.00147	0.00508	CcSEcCtD
Halofantrine—Myalgia—Melphalan—ovarian cancer	0.00147	0.00508	CcSEcCtD
Halofantrine—Abdominal distension—Paclitaxel—ovarian cancer	0.00146	0.00506	CcSEcCtD
Halofantrine—Back pain—Vinorelbine—ovarian cancer	0.00146	0.00504	CcSEcCtD
Halofantrine—Anaphylactic shock—Topotecan—ovarian cancer	0.00144	0.00497	CcSEcCtD
Halofantrine—Dyspepsia—Chlorambucil—ovarian cancer	0.00142	0.00492	CcSEcCtD
Halofantrine—Anaphylactic shock—Melphalan—ovarian cancer	0.00141	0.00487	CcSEcCtD
Halofantrine—Decreased appetite—Chlorambucil—ovarian cancer	0.0014	0.00485	CcSEcCtD
Halofantrine—Ill-defined disorder—Vinorelbine—ovarian cancer	0.0014	0.00483	CcSEcCtD
Halofantrine—Fatigue—Chlorambucil—ovarian cancer	0.00139	0.00481	CcSEcCtD
Halofantrine—Anorexia—Topotecan—ovarian cancer	0.00137	0.00474	CcSEcCtD
Halofantrine—Malaise—Vinorelbine—ovarian cancer	0.00136	0.0047	CcSEcCtD
Halofantrine—Pollakiuria—Paclitaxel—ovarian cancer	0.00134	0.00465	CcSEcCtD
Halofantrine—Anorexia—Melphalan—ovarian cancer	0.00134	0.00464	CcSEcCtD
Halofantrine—Palpitations—Vinorelbine—ovarian cancer	0.00133	0.0046	CcSEcCtD
Halofantrine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00133	0.0046	CcSEcCtD
Halofantrine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00132	0.00457	CcSEcCtD
Halofantrine—Cough—Vinorelbine—ovarian cancer	0.00131	0.00455	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00131	0.00453	CcSEcCtD
Halofantrine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.0013	0.00451	CcSEcCtD
Halofantrine—Paraesthesia—Topotecan—ovarian cancer	0.00129	0.00446	CcSEcCtD
Halofantrine—Urticaria—Chlorambucil—ovarian cancer	0.00128	0.00444	CcSEcCtD
Halofantrine—Myalgia—Vinorelbine—ovarian cancer	0.00128	0.00444	CcSEcCtD
Halofantrine—Arthralgia—Vinorelbine—ovarian cancer	0.00128	0.00444	CcSEcCtD
Halofantrine—Chest pain—Vinorelbine—ovarian cancer	0.00128	0.00444	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00128	0.00443	CcSEcCtD
Halofantrine—Abdominal pain—Chlorambucil—ovarian cancer	0.00128	0.00441	CcSEcCtD
Halofantrine—Discomfort—Vinorelbine—ovarian cancer	0.00127	0.00438	CcSEcCtD
Halofantrine—Dyspepsia—Topotecan—ovarian cancer	0.00127	0.00438	CcSEcCtD
Halofantrine—Stomatitis—Paclitaxel—ovarian cancer	0.00126	0.00437	CcSEcCtD
Halofantrine—Paraesthesia—Melphalan—ovarian cancer	0.00126	0.00437	CcSEcCtD
Halofantrine—Decreased appetite—Topotecan—ovarian cancer	0.00125	0.00432	CcSEcCtD
Halofantrine—Fatigue—Topotecan—ovarian cancer	0.00124	0.00429	CcSEcCtD
Halofantrine—Dyspepsia—Melphalan—ovarian cancer	0.00124	0.00428	CcSEcCtD
Halofantrine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00123	0.00425	CcSEcCtD
Halofantrine—Constipation—Topotecan—ovarian cancer	0.00123	0.00425	CcSEcCtD
Halofantrine—Decreased appetite—Melphalan—ovarian cancer	0.00122	0.00423	CcSEcCtD
Halofantrine—Fatigue—Melphalan—ovarian cancer	0.00121	0.0042	CcSEcCtD
Halofantrine—Feeling abnormal—Topotecan—ovarian cancer	0.00118	0.0041	CcSEcCtD
Halofantrine—Pulmonary oedema—Epirubicin—ovarian cancer	0.00118	0.00408	CcSEcCtD
Halofantrine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00118	0.00407	CcSEcCtD
Halofantrine—Anorexia—Vinorelbine—ovarian cancer	0.00117	0.00405	CcSEcCtD
Halofantrine—Asthenia—Chlorambucil—ovarian cancer	0.00116	0.00401	CcSEcCtD
Halofantrine—Abnormal vision—Epirubicin—ovarian cancer	0.00116	0.004	CcSEcCtD
Halofantrine—Pruritus—Chlorambucil—ovarian cancer	0.00114	0.00395	CcSEcCtD
Halofantrine—Urticaria—Topotecan—ovarian cancer	0.00114	0.00395	CcSEcCtD
Halofantrine—Abdominal pain—Topotecan—ovarian cancer	0.00114	0.00393	CcSEcCtD
Halofantrine—Visual impairment—Paclitaxel—ovarian cancer	0.00112	0.00388	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00112	0.00387	CcSEcCtD
Halofantrine—Urticaria—Melphalan—ovarian cancer	0.00112	0.00387	CcSEcCtD
Halofantrine—Diarrhoea—Chlorambucil—ovarian cancer	0.0011	0.00382	CcSEcCtD
Halofantrine—Paraesthesia—Vinorelbine—ovarian cancer	0.0011	0.00382	CcSEcCtD
Halofantrine—Pulmonary oedema—Doxorubicin—ovarian cancer	0.00109	0.00378	CcSEcCtD
Halofantrine—Tinnitus—Paclitaxel—ovarian cancer	0.00109	0.00375	CcSEcCtD
Halofantrine—Stomatitis—Docetaxel—ovarian cancer	0.00107	0.00371	CcSEcCtD
Halofantrine—Abnormal vision—Doxorubicin—ovarian cancer	0.00107	0.0037	CcSEcCtD
Halofantrine—Decreased appetite—Vinorelbine—ovarian cancer	0.00107	0.0037	CcSEcCtD
Halofantrine—Fatigue—Vinorelbine—ovarian cancer	0.00106	0.00367	CcSEcCtD
Halofantrine—Constipation—Vinorelbine—ovarian cancer	0.00105	0.00364	CcSEcCtD
Halofantrine—Chills—Paclitaxel—ovarian cancer	0.00104	0.00361	CcSEcCtD
Halofantrine—Arrhythmia—Paclitaxel—ovarian cancer	0.00104	0.0036	CcSEcCtD
Halofantrine—Asthenia—Topotecan—ovarian cancer	0.00103	0.00357	CcSEcCtD
Halofantrine—Vomiting—Chlorambucil—ovarian cancer	0.00103	0.00355	CcSEcCtD
Halofantrine—Pruritus—Topotecan—ovarian cancer	0.00102	0.00352	CcSEcCtD
Halofantrine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00101	0.0035	CcSEcCtD
Halofantrine—Asthenia—Melphalan—ovarian cancer	0.00101	0.00349	CcSEcCtD
Halofantrine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00101	0.00348	CcSEcCtD
Halofantrine—Pruritus—Melphalan—ovarian cancer	0.000996	0.00344	CcSEcCtD
Halofantrine—Diarrhoea—Topotecan—ovarian cancer	0.000984	0.0034	CcSEcCtD
Halofantrine—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000982	0.0034	CcSEcCtD
Halofantrine—Back pain—Paclitaxel—ovarian cancer	0.00098	0.00339	CcSEcCtD
Halofantrine—Urticaria—Vinorelbine—ovarian cancer	0.000977	0.00338	CcSEcCtD
Halofantrine—Abdominal pain—Vinorelbine—ovarian cancer	0.000972	0.00336	CcSEcCtD
Halofantrine—Diarrhoea—Melphalan—ovarian cancer	0.000963	0.00333	CcSEcCtD
Halofantrine—Nausea—Chlorambucil—ovarian cancer	0.000959	0.00332	CcSEcCtD
Halofantrine—Visual impairment—Docetaxel—ovarian cancer	0.000951	0.00329	CcSEcCtD
Halofantrine—Dizziness—Topotecan—ovarian cancer	0.000951	0.00329	CcSEcCtD
Halofantrine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00094	0.00325	CcSEcCtD
Halofantrine—Face oedema—Epirubicin—ovarian cancer	0.000929	0.00321	CcSEcCtD
Halofantrine—Vomiting—Topotecan—ovarian cancer	0.000914	0.00316	CcSEcCtD
Halofantrine—Malaise—Paclitaxel—ovarian cancer	0.000914	0.00316	CcSEcCtD
Halofantrine—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000908	0.00314	CcSEcCtD
Halofantrine—Rash—Topotecan—ovarian cancer	0.000906	0.00313	CcSEcCtD
Halofantrine—Dermatitis—Topotecan—ovarian cancer	0.000906	0.00313	CcSEcCtD
Halofantrine—Headache—Topotecan—ovarian cancer	0.000901	0.00311	CcSEcCtD
Halofantrine—Palpitations—Paclitaxel—ovarian cancer	0.000896	0.0031	CcSEcCtD
Halofantrine—Vomiting—Melphalan—ovarian cancer	0.000895	0.0031	CcSEcCtD
Halofantrine—Rash—Melphalan—ovarian cancer	0.000888	0.00307	CcSEcCtD
Halofantrine—Dermatitis—Melphalan—ovarian cancer	0.000887	0.00307	CcSEcCtD
Halofantrine—Chills—Docetaxel—ovarian cancer	0.000885	0.00306	CcSEcCtD
Halofantrine—Cough—Paclitaxel—ovarian cancer	0.000884	0.00306	CcSEcCtD
Halofantrine—Asthenia—Vinorelbine—ovarian cancer	0.000882	0.00305	CcSEcCtD
Halofantrine—Arrhythmia—Docetaxel—ovarian cancer	0.000882	0.00305	CcSEcCtD
Halofantrine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000879	0.00304	CcSEcCtD
Halofantrine—Convulsion—Paclitaxel—ovarian cancer	0.000878	0.00304	CcSEcCtD
Halofantrine—Pruritus—Vinorelbine—ovarian cancer	0.00087	0.00301	CcSEcCtD
Halofantrine—Arthralgia—Paclitaxel—ovarian cancer	0.000863	0.00298	CcSEcCtD
Halofantrine—Chest pain—Paclitaxel—ovarian cancer	0.000863	0.00298	CcSEcCtD
Halofantrine—Myalgia—Paclitaxel—ovarian cancer	0.000863	0.00298	CcSEcCtD
Halofantrine—Face oedema—Doxorubicin—ovarian cancer	0.000859	0.00297	CcSEcCtD
Halofantrine—Nausea—Topotecan—ovarian cancer	0.000854	0.00295	CcSEcCtD
Halofantrine—Discomfort—Paclitaxel—ovarian cancer	0.000853	0.00295	CcSEcCtD
Halofantrine—Diarrhoea—Vinorelbine—ovarian cancer	0.000841	0.00291	CcSEcCtD
Halofantrine—Abdominal distension—Epirubicin—ovarian cancer	0.000837	0.0029	CcSEcCtD
Halofantrine—Nausea—Melphalan—ovarian cancer	0.000836	0.00289	CcSEcCtD
Halofantrine—Confusional state—Paclitaxel—ovarian cancer	0.000834	0.00288	CcSEcCtD
Halofantrine—Back pain—Docetaxel—ovarian cancer	0.000831	0.00287	CcSEcCtD
Halofantrine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000827	0.00286	CcSEcCtD
Halofantrine—Dizziness—Vinorelbine—ovarian cancer	0.000813	0.00281	CcSEcCtD
Halofantrine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000813	0.00281	CcSEcCtD
Halofantrine—Anorexia—Paclitaxel—ovarian cancer	0.000788	0.00273	CcSEcCtD
Halofantrine—Vomiting—Vinorelbine—ovarian cancer	0.000782	0.0027	CcSEcCtD
Halofantrine—Rash—Vinorelbine—ovarian cancer	0.000775	0.00268	CcSEcCtD
Halofantrine—Dermatitis—Vinorelbine—ovarian cancer	0.000775	0.00268	CcSEcCtD
Halofantrine—Abdominal distension—Doxorubicin—ovarian cancer	0.000775	0.00268	CcSEcCtD
Halofantrine—Headache—Vinorelbine—ovarian cancer	0.00077	0.00266	CcSEcCtD
Halofantrine—Pollakiuria—Epirubicin—ovarian cancer	0.000768	0.00266	CcSEcCtD
Halofantrine—Palpitations—Docetaxel—ovarian cancer	0.000759	0.00263	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000754	0.00261	CcSEcCtD
Halofantrine—Cough—Docetaxel—ovarian cancer	0.00075	0.00259	CcSEcCtD
Halofantrine—Convulsion—Docetaxel—ovarian cancer	0.000744	0.00257	CcSEcCtD
Halofantrine—Paraesthesia—Paclitaxel—ovarian cancer	0.000743	0.00257	CcSEcCtD
Halofantrine—Chest pain—Docetaxel—ovarian cancer	0.000731	0.00253	CcSEcCtD
Halofantrine—Myalgia—Docetaxel—ovarian cancer	0.000731	0.00253	CcSEcCtD
Halofantrine—Arthralgia—Docetaxel—ovarian cancer	0.000731	0.00253	CcSEcCtD
Halofantrine—Nausea—Vinorelbine—ovarian cancer	0.00073	0.00253	CcSEcCtD
Halofantrine—Dyspepsia—Paclitaxel—ovarian cancer	0.000728	0.00252	CcSEcCtD
Halofantrine—Stomatitis—Epirubicin—ovarian cancer	0.000723	0.0025	CcSEcCtD
Halofantrine—Decreased appetite—Paclitaxel—ovarian cancer	0.000719	0.00249	CcSEcCtD
Halofantrine—Fatigue—Paclitaxel—ovarian cancer	0.000713	0.00247	CcSEcCtD
Halofantrine—Pollakiuria—Doxorubicin—ovarian cancer	0.000711	0.00246	CcSEcCtD
Halofantrine—Constipation—Paclitaxel—ovarian cancer	0.000707	0.00245	CcSEcCtD
Halofantrine—Confusional state—Docetaxel—ovarian cancer	0.000707	0.00244	CcSEcCtD
Halofantrine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000701	0.00242	CcSEcCtD
Halofantrine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000682	0.00236	CcSEcCtD
Halofantrine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000676	0.00234	CcSEcCtD
Halofantrine—Stomatitis—Doxorubicin—ovarian cancer	0.000669	0.00231	CcSEcCtD
Halofantrine—Anorexia—Docetaxel—ovarian cancer	0.000668	0.00231	CcSEcCtD
Halofantrine—Urticaria—Paclitaxel—ovarian cancer	0.000657	0.00227	CcSEcCtD
Halofantrine—Abdominal pain—Paclitaxel—ovarian cancer	0.000654	0.00226	CcSEcCtD
Halofantrine—Visual impairment—Epirubicin—ovarian cancer	0.000641	0.00222	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000639	0.00221	CcSEcCtD
Halofantrine—Paraesthesia—Docetaxel—ovarian cancer	0.00063	0.00218	CcSEcCtD
Halofantrine—Tinnitus—Epirubicin—ovarian cancer	0.000621	0.00215	CcSEcCtD
Halofantrine—Dyspepsia—Docetaxel—ovarian cancer	0.000617	0.00213	CcSEcCtD
Halofantrine—Decreased appetite—Docetaxel—ovarian cancer	0.000609	0.00211	CcSEcCtD
Halofantrine—Fatigue—Docetaxel—ovarian cancer	0.000604	0.00209	CcSEcCtD
Halofantrine—Constipation—Docetaxel—ovarian cancer	0.0006	0.00207	CcSEcCtD
Halofantrine—Chills—Epirubicin—ovarian cancer	0.000597	0.00207	CcSEcCtD
Halofantrine—Arrhythmia—Epirubicin—ovarian cancer	0.000595	0.00206	CcSEcCtD
Halofantrine—Visual impairment—Doxorubicin—ovarian cancer	0.000594	0.00205	CcSEcCtD
Halofantrine—Asthenia—Paclitaxel—ovarian cancer	0.000593	0.00205	CcSEcCtD
Halofantrine—Pruritus—Paclitaxel—ovarian cancer	0.000585	0.00202	CcSEcCtD
Halofantrine—Feeling abnormal—Docetaxel—ovarian cancer	0.000578	0.002	CcSEcCtD
Halofantrine—Tinnitus—Doxorubicin—ovarian cancer	0.000574	0.00199	CcSEcCtD
Halofantrine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000573	0.00198	CcSEcCtD
Halofantrine—Diarrhoea—Paclitaxel—ovarian cancer	0.000566	0.00196	CcSEcCtD
Halofantrine—Back pain—Epirubicin—ovarian cancer	0.00056	0.00194	CcSEcCtD
Halofantrine—Abdominal pain—Docetaxel—ovarian cancer	0.000554	0.00192	CcSEcCtD
Halofantrine—Chills—Doxorubicin—ovarian cancer	0.000553	0.00191	CcSEcCtD
Halofantrine—Arrhythmia—Doxorubicin—ovarian cancer	0.00055	0.0019	CcSEcCtD
Halofantrine—Dizziness—Paclitaxel—ovarian cancer	0.000547	0.00189	CcSEcCtD
Halofantrine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000538	0.00186	CcSEcCtD
Halofantrine—Vomiting—Paclitaxel—ovarian cancer	0.000526	0.00182	CcSEcCtD
Halofantrine—Malaise—Epirubicin—ovarian cancer	0.000523	0.00181	CcSEcCtD
Halofantrine—Rash—Paclitaxel—ovarian cancer	0.000522	0.0018	CcSEcCtD
Halofantrine—Dermatitis—Paclitaxel—ovarian cancer	0.000521	0.0018	CcSEcCtD
Halofantrine—Back pain—Doxorubicin—ovarian cancer	0.000519	0.00179	CcSEcCtD
Halofantrine—Headache—Paclitaxel—ovarian cancer	0.000518	0.00179	CcSEcCtD
Halofantrine—Palpitations—Epirubicin—ovarian cancer	0.000512	0.00177	CcSEcCtD
Halofantrine—Cough—Epirubicin—ovarian cancer	0.000506	0.00175	CcSEcCtD
Halofantrine—Asthenia—Docetaxel—ovarian cancer	0.000503	0.00174	CcSEcCtD
Halofantrine—Convulsion—Epirubicin—ovarian cancer	0.000502	0.00174	CcSEcCtD
Halofantrine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000497	0.00172	CcSEcCtD
Halofantrine—Pruritus—Docetaxel—ovarian cancer	0.000496	0.00172	CcSEcCtD
Halofantrine—Arthralgia—Epirubicin—ovarian cancer	0.000493	0.00171	CcSEcCtD
Halofantrine—Chest pain—Epirubicin—ovarian cancer	0.000493	0.00171	CcSEcCtD
Halofantrine—Myalgia—Epirubicin—ovarian cancer	0.000493	0.00171	CcSEcCtD
Halofantrine—Nausea—Paclitaxel—ovarian cancer	0.000491	0.0017	CcSEcCtD
Halofantrine—Discomfort—Epirubicin—ovarian cancer	0.000487	0.00169	CcSEcCtD
Halofantrine—Malaise—Doxorubicin—ovarian cancer	0.000483	0.00167	CcSEcCtD
Halofantrine—Diarrhoea—Docetaxel—ovarian cancer	0.00048	0.00166	CcSEcCtD
Halofantrine—Confusional state—Epirubicin—ovarian cancer	0.000477	0.00165	CcSEcCtD
Halofantrine—Palpitations—Doxorubicin—ovarian cancer	0.000474	0.00164	CcSEcCtD
Halofantrine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000473	0.00164	CcSEcCtD
Halofantrine—Cough—Doxorubicin—ovarian cancer	0.000468	0.00162	CcSEcCtD
Halofantrine—Convulsion—Doxorubicin—ovarian cancer	0.000465	0.00161	CcSEcCtD
Halofantrine—Dizziness—Docetaxel—ovarian cancer	0.000464	0.0016	CcSEcCtD
Halofantrine—Chest pain—Doxorubicin—ovarian cancer	0.000456	0.00158	CcSEcCtD
Halofantrine—Myalgia—Doxorubicin—ovarian cancer	0.000456	0.00158	CcSEcCtD
Halofantrine—Arthralgia—Doxorubicin—ovarian cancer	0.000456	0.00158	CcSEcCtD
Halofantrine—Discomfort—Doxorubicin—ovarian cancer	0.000451	0.00156	CcSEcCtD
Halofantrine—Anorexia—Epirubicin—ovarian cancer	0.000451	0.00156	CcSEcCtD
Halofantrine—Vomiting—Docetaxel—ovarian cancer	0.000446	0.00154	CcSEcCtD
Halofantrine—Rash—Docetaxel—ovarian cancer	0.000442	0.00153	CcSEcCtD
Halofantrine—Dermatitis—Docetaxel—ovarian cancer	0.000442	0.00153	CcSEcCtD
Halofantrine—Confusional state—Doxorubicin—ovarian cancer	0.000441	0.00153	CcSEcCtD
Halofantrine—Headache—Docetaxel—ovarian cancer	0.000439	0.00152	CcSEcCtD
Halofantrine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000438	0.00151	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000431	0.00149	CcSEcCtD
Halofantrine—Paraesthesia—Epirubicin—ovarian cancer	0.000425	0.00147	CcSEcCtD
Halofantrine—Anorexia—Doxorubicin—ovarian cancer	0.000417	0.00144	CcSEcCtD
Halofantrine—Nausea—Docetaxel—ovarian cancer	0.000416	0.00144	CcSEcCtD
Halofantrine—Dyspepsia—Epirubicin—ovarian cancer	0.000416	0.00144	CcSEcCtD
Halofantrine—Decreased appetite—Epirubicin—ovarian cancer	0.000411	0.00142	CcSEcCtD
Halofantrine—Fatigue—Epirubicin—ovarian cancer	0.000408	0.00141	CcSEcCtD
Halofantrine—Constipation—Epirubicin—ovarian cancer	0.000404	0.0014	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000399	0.00138	CcSEcCtD
Halofantrine—Paraesthesia—Doxorubicin—ovarian cancer	0.000393	0.00136	CcSEcCtD
Halofantrine—Feeling abnormal—Epirubicin—ovarian cancer	0.00039	0.00135	CcSEcCtD
Halofantrine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000387	0.00134	CcSEcCtD
Halofantrine—Dyspepsia—Doxorubicin—ovarian cancer	0.000385	0.00133	CcSEcCtD
Halofantrine—Decreased appetite—Doxorubicin—ovarian cancer	0.00038	0.00132	CcSEcCtD
Halofantrine—Fatigue—Doxorubicin—ovarian cancer	0.000377	0.0013	CcSEcCtD
Halofantrine—Urticaria—Epirubicin—ovarian cancer	0.000376	0.0013	CcSEcCtD
Halofantrine—Constipation—Doxorubicin—ovarian cancer	0.000374	0.00129	CcSEcCtD
Halofantrine—Abdominal pain—Epirubicin—ovarian cancer	0.000374	0.00129	CcSEcCtD
Halofantrine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000361	0.00125	CcSEcCtD
Halofantrine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000358	0.00124	CcSEcCtD
Halofantrine—Urticaria—Doxorubicin—ovarian cancer	0.000348	0.0012	CcSEcCtD
Halofantrine—Abdominal pain—Doxorubicin—ovarian cancer	0.000346	0.0012	CcSEcCtD
Halofantrine—Asthenia—Epirubicin—ovarian cancer	0.000339	0.00117	CcSEcCtD
Halofantrine—Pruritus—Epirubicin—ovarian cancer	0.000335	0.00116	CcSEcCtD
Halofantrine—Diarrhoea—Epirubicin—ovarian cancer	0.000324	0.00112	CcSEcCtD
Halofantrine—Asthenia—Doxorubicin—ovarian cancer	0.000314	0.00109	CcSEcCtD
Halofantrine—Dizziness—Epirubicin—ovarian cancer	0.000313	0.00108	CcSEcCtD
Halofantrine—Pruritus—Doxorubicin—ovarian cancer	0.00031	0.00107	CcSEcCtD
Halofantrine—Vomiting—Epirubicin—ovarian cancer	0.000301	0.00104	CcSEcCtD
Halofantrine—Diarrhoea—Doxorubicin—ovarian cancer	0.000299	0.00104	CcSEcCtD
Halofantrine—Rash—Epirubicin—ovarian cancer	0.000298	0.00103	CcSEcCtD
Halofantrine—Dermatitis—Epirubicin—ovarian cancer	0.000298	0.00103	CcSEcCtD
Halofantrine—Headache—Epirubicin—ovarian cancer	0.000296	0.00102	CcSEcCtD
Halofantrine—Dizziness—Doxorubicin—ovarian cancer	0.000289	0.001	CcSEcCtD
Halofantrine—Nausea—Epirubicin—ovarian cancer	0.000281	0.000971	CcSEcCtD
Halofantrine—Vomiting—Doxorubicin—ovarian cancer	0.000278	0.000962	CcSEcCtD
Halofantrine—Rash—Doxorubicin—ovarian cancer	0.000276	0.000954	CcSEcCtD
Halofantrine—Dermatitis—Doxorubicin—ovarian cancer	0.000276	0.000953	CcSEcCtD
Halofantrine—Headache—Doxorubicin—ovarian cancer	0.000274	0.000948	CcSEcCtD
Halofantrine—Nausea—Doxorubicin—ovarian cancer	0.00026	0.000899	CcSEcCtD
